Furthermore, single-nucleotide polymorphisms (SNPs) in human GSTO1 and GSTO2 have been associated with the age at onset of Alzheimer’s disease (AD) and Parkinson’s disease (PD). Here, GSTO1 is linked to Parkinson disease.